SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-03-026265
Filing Date
2003-07-30
Accepted
2003-07-30 14:06:15
Documents
6
Period of Report
2003-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 535963
3 AMENDED AND RESTATED BYLAWS OF AMGEN, INC. dex32.htm EX-3.2 102466
4 COMPANY'S AMENDED AND RESTATED 1997 EQUITY INCENTIVE PLAN dex102.htm EX-10.2 60181
5 RESTRICTED STOCK PURCHASE AGREEMENT BETWEEN AMGEN INC. AND BRIAN M. MCNAMEE dex1091.htm EX-10.91 19683
6 RULE 13A-14(A) CERTIFICATIONS dex31.htm EX-31 19379
7 SECTION 1350 CERTIFICATIONS dex321.htm EX-32 9756
  Complete submission text file 0001193125-03-026265.txt   749750
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-12477 | Film No.: 03811038
SIC: 2836 Biological Products, (No Diagnostic Substances)